Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 21:4:581-90.
doi: 10.2147/opth.s10337.

Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension

Cindy Hutnik  1 , David Neima, Fahim Ibrahim, Robert Scott, Julie Vaillancourt, Denis Haine, John S Sampalis, Natacha Bastien, Sylvain Foucart
Affiliations

Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension

Cindy Hutnik et al. Clin Ophthalmol. .

Abstract

Purpose: To assess the effect of preservative-free dorzolamide-timolol on nonvisual symptoms and intraocular pressure (IOP) in newly diagnosed and untreated patients with open-angle glaucoma or ocular hypertension.

Methods: This was a prospective, 8-week, open-label, Canadian multicenter study. All patients were treated with preservative-free dorzolamide-timolol formulation. The primary outcome was the change in the nonvisual symptom score of the Glaucoma Symptom Scale (GSS-SYMP-6) from baseline to 8 weeks. Secondary effectiveness outcome measures were absolute and percent changes in IOP from baseline to 4 and 8 weeks.

Results: One hundred and seventy-eight patients were enrolled. Mean (SD) age was 65.6 (12.1) years and 90 (50.6%) were females. There were 92 patients diagnosed with open-angle glaucoma, 62 with ocular hypertension, and 23 with both diseases (diagnosis was missing for one patient). The mean (SD) GSS-SYMP-6 score increased from 73.6 (21.8) at baseline to 76.1 (20.7) at 8 weeks (P = 0.097). Mean (SD) IOP significantly decreased by 11.7 (5.1) mmHg at 4 weeks (P < 0.001) and by 11.5 (5.3) mmHg at 8 weeks (P < 0.001), representing reductions of -38.5% (P < 0.001) and -38.0% (P < 0.001), respectively.

Conclusion: Preservative-free dorzolamide-timolol does not increase eye discomfort while significantly reducing IOP in patients with open-angle glaucoma or ocular-hypertension.

Keywords: GSS-SYMP-6; dorzolamide–timolol; intraocular pressure; ocular hypertension; open-angle glaucoma; preservative-free.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percent change in intraocular pressure (IOP) of the worse eye between week 4 and baseline.
Figure 2
Figure 2
Percent change in intraocular pressure (IOP) of the worse eye between week 8 and baseline.
Figure 3
Figure 3
Patients’ and ophthalmologists’ global satisfaction with 8 weeks preservative-free dorzolamide–timolol treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090–1095. - PubMed
    1. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004;82(11):844–852. - PMC - PubMed
    1. Adatia FA, Damji KF. Chronic open-angle glaucoma. Review for primary care physicians. Can Fam Physician. 2005;51:1229–1237. - PMC - PubMed
    1. Lee AG, Beaver HA. Visual loss in the elderly – Part I: Chronic visual loss: what to recognize and when to refer. Clin Geriatr. 2003;11(6):46–53.
    1. Rouland JF, Berdeaux G, Lafuma A. The economic burden of glaucoma and ocular hypertension: implications for patient management: a review. Drugs Aging. 2005;22(4):315–321. - PubMed